Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD–transformed hematopoietic cells (Q40618806)
Jump to navigation
Jump to search
scientific article published on November 6, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD–transformed hematopoietic cells |
scientific article published on November 6, 2003 |
Statements
1 reference
Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cells (English)
1 reference
Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD–transformed hematopoietic cells (English)
1 reference
1 reference
1 reference
Susanne Schnittger
1 reference
Ksenia Bagrintseva
1 reference
Ruth Schwab
1 reference
Sabine Eichenlaub
1 reference
Wolfgang Hiddemann
1 reference
Karsten Spiekermann
1 reference
Tobias M. Kohl
Joachim W. Ellwart
6 November 2003
1 reference
2266-2275
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference